CD4 +CD25 +Foxp3 +IFN-γ + human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically

Human Immunology

Volumn 72, Issue 9, 2011, Pages 699-707

  Daniel, Volker ^a   Sadeghi, Mahmoud ^a   Wang, Haihao ^a,b   Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alloresponse; Antigen nonspecific immunosuppression; Foxp3+IFN +; Graft outcome; IFN ; Induced Treg; MLC; Renal transplantation

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT INTERFERON; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MIXED LEUKOCYTE CULTURE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD4; CELL SEPARATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 84860390070     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.020     Document Type: Article

References (28)

1. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
2. Zheng S.G., Wang J.H., Gray J.D., Soucier H., Horwitz D.A. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 2004, 172:5213-5221.
3. Sakaguchi S., Wing K., Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol 2009, 39:2331-2336.
4. Stroopinsky D., Avivi I., Rowe J.M., Avigan D., Katz T. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity. Eur J Immunol 2009, 39:2703-2715.
5. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8:277-284.
6. Sawitzki B., Kingsley C.I., Oliveira V., Karim M., Herber M., Wood K.J. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005, 201:1925-1935.
7. Wei B., Baker S., Wieckiewicz J., Wood K.J. IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. Am J Transplant 2010, 10:69-80.
8. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
9. Xu L., Kitani A., Fuss I., Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007, 178:6725-6729.
10. Osorio F., LeibundGut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008, 38:3274-3281.
11. Wei G., Wei L., Zhu J., Zang C., Hu-Li J., Yao Z., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
12. Feng T, Cao AT, Weaver CT, Elson CO, Cong Y. IL-12 converts Foxp3(+) regulatory T cells to Foxp3(+)IFN-gamma(+) T cells with inhibitory functions during induction of colitis. Gastroenterology. Epub ahead of print 17 March 2011.
13. Daniel V., Naujokat C., Sadeghi M., Weimer R., Renner F., Yildiz S., et al. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl Int 2008, 21:646-660.
14. McClymont S.A., Putnam A.L., Lee M.R., Esensten J.H., Liu W., Hulme M.A., et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011, 186:3918-3926.
15. Pillai V., Ortega S.B., Wang C.K., Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007, 123:18-29.
16. Bach E.A., Aguet M., Schreiber R.D. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997, 15:563-591.
17. Valente G., Ozmen L., Novelli F., Geuna M., Palestro G., Forni G., et al. Distribution of interferon-gamma receptor in human tissues. Eur J Immunol 1992, 22:2403-2412.
18. Wood K.J., Sawitzki B. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006, 27:183-187.
19. Selvaraj R.K., Geiger T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 2007, 178:7667-7677.
20. Yi H., Zhen Y., Jiang L., Zheng J., Zhao Y. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell Mol Immunol 2006, 3:189-195.
21. Feng G., Wood K.J., Bushell A. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation 2008, 86:578-589.
22. Sadeghi M., Daniel V., Naujokat C., Schmidt J., Mehrabi A., Zeier M., et al. Evidence for IFN-gamma up- and IL-4 downregulation late post-transplant in patients with good kidney graft outcome. Clin Transpl 2007, 21:449-459.
23. Daniel V., Naujokat C., Sadeghi M., Wiesel M., Hergesell O., Opelz G. Association of circulating interleukin (IL)-12- and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients. Transplantation 2005, 79:1498-1506.
24. Markees T.G., Phillips N.E., Gordon E.J., Noelle R.J., Shultz L.D., Mordes J.P., et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest 1998, 101:2446-2455.
25. Konieczny B.T., Dai Z., Elwood E.T., Saleem S., Linsley P.S., Baddoura F.K., et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998, 160:2059-2064.
26. Paineau J., Priestley C., Fabre J., Chevalier S., van der Meide P., Schellekens H., et al. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts. J Heart Lung Transplant 1991, 10:424-430.
27. Wei J., Duramad O., Perng O.A., Reiner S.L., Liu Y.J., Qin F.X. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 2007, 104:18169-18174.
28. Komatsu N., Mariotti-Ferrandiz M.E., Wang Y., Malissen B., Waldmann H., Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 2009, 106:1903-1908.